NCT05404594

Brief Summary

The management of pain related to venipuncture remains insufficient in very preterm infants (VPI. The separation between the mother (father) and her(his) child can aggravate the short-term painful experience of the newborn. Accurate diagnosis and treatment of pain is necessary to preserve the well-being and brain development of VPI. A better understanding of the development of pain pathways and the cortical integration of nociceptive messages is essential to reach this goal.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2019

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 3, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2023

Completed
Last Updated

January 30, 2023

Status Verified

January 1, 2023

Enrollment Period

3.8 years

First QC Date

February 21, 2022

Last Update Submit

January 27, 2023

Conditions

Keywords

Very preterm infantsDevelopment of nociceptionCortical hemodynamic responsesPain indicatorsGenderMaternal voiceOxytocin

Outcome Measures

Primary Outcomes (4)

  • The cortical hemodynamic response profile

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

    During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI

  • The cortical hemodynamic response profile

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

    During a venipuncture at 34 (+/-2) weeks PMAs in VPI

  • The cortical hemodynamic response profile

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

    During a venipuncture at 40 (+/-2) weeks PMAs in VPI

  • The cortical hemodynamic response profile

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

    During a venipuncture at 2 to 3 days of life in term neonates

Secondary Outcomes (32)

  • Comparison of the hemodynamic response profiles and salivary oxytocin levels

    During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI

  • Comparison of the hemodynamic response profiles and salivary oxytocin levels

    During a venipuncture at 34 (+/-2) weeks PMAs in VPI

  • Comparison of the hemodynamic response profiles and salivary oxytocin levels

    During a venipuncture at 40 (+/-2) weeks PMAs in VPI

  • Comparison of the hemodynamic response profiles and salivary oxytocin levels

    During a venipuncture at 2 to 3 days of life in term neonates

  • Analysis of the impact on the responses of maternal separation

    During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI

  • +27 more secondary outcomes

Study Arms (2)

Very preterm infant

EXPERIMENTAL

Preterm infant below 33 weeks of GA

Behavioral: Maternal vocal contact

Full term neonate

ACTIVE COMPARATOR

Term neonate from a gestational age of 37 weeks.

Behavioral: Maternal vocal contact

Interventions

Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Full term neonateVery preterm infant

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)
  • Control group: Healthy full-term babies (\> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital
  • Consent obtained from both parents
  • Subject affiliated to a social health insurance plan.

You may not qualify if:

  • Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)
  • Unstable clinical status according to the investigator's judgment
  • Expected transfer of the child to another hospital before the term of 40 weeks PMAs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Pédiatrie - Hôpital d'Hautepierre

Strasbourg, 67000, France

RECRUITING

MeSH Terms

Conditions

Pain, ProceduralPremature BirthCoitus

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSexual BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2022

First Posted

June 3, 2022

Study Start

July 17, 2019

Primary Completion

April 17, 2023

Study Completion

April 17, 2023

Last Updated

January 30, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations